Lupin Invests $250 Million in New Coral Springs Manufacturing Facility
Lupin, a global generics maker, is constructing a state-of-the-art pharma manufacturing facility in Coral Springs, FL, with an investment of approximately $250 million.
The new site will produce over 25 critical respiratory medicines, including albuterol inhalers for children with asthma and service members.
- Create over 200 jobs in the Broward County area by 2030
- Boost local manufacturing and supply chain diversification
- Strengthen domestic manufacturing and drug security
The new plant offers various positives, including a boost in local manufacturing, supply chain diversification, and the strengthening of drug security.
Author's summary: Lupin invests $250 million in a new manufacturing facility.
More News
- Liberty Hall to reprise its role as an opera house for centennial anniversary screening with live piano accompaniment
- Israeli media's distorted view of the war in Gaza
- 1st Test: Noman Ali’s 10-for seals 93-run win for Pakistan over South Africa
- Olivia Nuzzi to spill secrets of RFK Jr. sexting scandal in new book
- Ripples from the Reservoir: Mid-October edition — Waterbury Roundabout
- ChatGPT: so popular, hardly anyone will pay for it
- Brendan Gallagher: No-one is immune to this awful disease
- Universal Sets 2027 Release for Mysterious New Film From 'Everything Everywhere' Directors The Daniels
- Martin won't give up on Stawell dream, but for now the 400m is his focus
- Brendan Gallagher: Furious little bull who was as hard as nails